Psychotic Disorders - Morocco | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$15.51m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.02%, resulting in a market volume of US$15.52m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$39.22 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Morocco is experiencing significant growth and development due to several key factors. Customer preferences in the Psychotic Disorders market in Morocco are shifting towards more accessible and affordable treatment options. Patients are increasingly seeking out medications and therapies that are effective in managing their symptoms while also being cost-effective. This is driving pharmaceutical companies to develop new drugs and therapies that are specifically tailored to the needs of the Moroccan market. Additionally, there is a growing demand for holistic and alternative treatments, such as cognitive behavioral therapy and mindfulness-based interventions, which are gaining popularity among patients.One of the key trends in the Psychotic Disorders market in Morocco is the increasing use of technology in the diagnosis and treatment of mental health conditions. Telemedicine and online therapy platforms are becoming more prevalent, allowing patients to access mental health services remotely. This trend is particularly important in rural areas where access to mental health professionals may be limited. Additionally, the use of digital health tools, such as smartphone apps and wearable devices, is on the rise, enabling patients to track their symptoms and monitor their progress in real-time.Another trend in the Psychotic Disorders market in Morocco is the growing focus on early intervention and prevention. Healthcare providers and policymakers are recognizing the importance of early detection and treatment in improving outcomes for patients with psychotic disorders. Efforts are being made to raise awareness about the signs and symptoms of these conditions and to promote early intervention programs. This includes training healthcare professionals to identify and refer individuals who may be at risk of developing psychotic disorders.Local special circumstances in Morocco also play a role in the development of the Psychotic Disorders market. The country has a relatively young population, with a large proportion of the population under the age of 30. This demographic trend is driving the demand for mental health services, as young people are more likely to experience mental health problems. Additionally, Morocco has made significant investments in its healthcare infrastructure in recent years, which has improved access to mental health services for its population.Underlying macroeconomic factors are also contributing to the growth of the Psychotic Disorders market in Morocco. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income and healthcare spending. This has allowed individuals to seek out and afford mental health treatments and medications. Additionally, Morocco has a strong pharmaceutical industry, which is driving innovation and research in the field of mental health.Overall, the Psychotic Disorders market in Morocco is experiencing growth and development due to shifting customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. As the country continues to invest in its healthcare infrastructure and prioritize mental health, the market is expected to expand further in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.